Women's Nike Air Air Air Max Premiere Running shoes, 789574 106 Sizes 7.5-8.5 Wht Blk Pi f5e720

Posted July 11th, 2011 in Exits IPOs M&As, VC-backed Biotech Returns
  • Share via Twitter
  • Womens Nike Air Force 1 High FW QS New York NYC Light Bone SZ 7.5 (704010-001),
  • Share via Facebook
  • NIKE W Air Presto 878068-011 LIGHT PUMICE LIGHT PUMICE-GUNSMOKE Womens Size 9,
  • Share via LinkedIn
  • Womens Nike Mercurial Vapor XI FG Size 6 Soccer Cleats Pink 844235 610,
  • NIKE METCON 1 Lauren Fisher (813101 003) SZ WMNS 10,

Note to Readers: This blog post was co-written by Bruce Booth and Bijan Salehizadehwho co-authored an article in the July 2011 issue of Nature Biotechnologydetailing the differences in returns between Life Sciences and Tech investing.

NIKE SHOX SHOESHOT PINK SIZE 6 YOUTH WOMENS SZ 7.5 WORE TWICE,

NIKE W Nike Air Max 1 Ultra 2.0 881104-100 WHITE Size 6,

Left behind by this good news is the NEW NIKE AIR ZOOM PEGASUS 35 WOMENS RUNNING SNEAKERS Rush Pink 10.5 or 11, which according to PWCMoneyTree / NVCA data accounted for nearly 30% of the $21 billion invested in venture-backed companies in 2010.

Womens Nike Air Force 1 07 W size 11.5 BNIB,

Women's Nike Air Air Air Max Premiere Running shoes, 789574 106 Sizes 7.5-8.5 Wht Blk Pi f5e720Women's Nike Air Air Air Max Premiere Running shoes, 789574 106 Sizes 7.5-8.5 Wht Blk Pi f5e720

Nike Air Vapormax 2018 (WhBlk) Running Athletic-Women,.

As we outline in our paper in the July issue of Nature Biotechnology, LS venture investing dramatically outperformed Tech venture investing over the past decade.

Nike Air Max 90 Premium Women's shoes in Black Sail,

Nike Air Max 95 OG Women's shoes Size 9 Style 307960 111,

Overall Life Sciences/Healthcare venture realized gross pooled mean IRR was 15.0% for the past decade.  This is in contrast to 5.5% for all of venture capital, 3.0% for IT and 4.1% for Software.Nike Air Max 90 LEA 921304-601 Wmn Sz 6.5 Bordeaux Black White,.

NEW Women's Nike Air Max Zero shoes Sneakers Size 5 color Black MSRP 130,

Air Jordan Retro High Top Women’s EU Sizes 23,24 & 24.5,

There’s a perception that lots of Life Sciences deals lose money.  It’s true.  58% returned less than their invested capital.NIKE AIR MAX 95 ULTRA SZ WMNS 6.5 (749212 002),.  Furthermore, the frequency of 5x or greater returns are higher in Life Sciences – 8% vs. 4% for IT.Air Jordan 1 Low Slip NRG Womans. Size 8.5. Brand New. Varsity Red Black-White.,.g.,. top 1% of Tech deals almost certainly have higher multiples than LS).

WOMEN'S NIKE AIR MORE UPTEMPO SHOES CHROME WHITE 917593-100 SIZE 8.5,.

But, as one would expect, not all of the news for Life Sciences is rosy:

Nike Free RN 2018 Women's Black Anthracite 42837002,

NIKE AIR MORE UPTEMPO BLACK HOT PUNCH VOLT 917593 002 Women size 8,..  And, post-IPO performance has been dramatically better in IT than it has been in Life Sciences.Nike Zoom Pegasus 34 Shiled (GS) Running shoes Black Volt Women’s 8,6.5Y 92285001,.

Wmns Nike Duel Racer Diffused bluee pink Women Running shoes Sneakers 927243-401,.  IPOs are media darlings, and help create buzz about sectors.  In LS, we aren’t likely to have that type of buzz anytime soon.

Our data and analysis of course has some short-comings.Women's Nike Air Max Torch 4 Running Training shoes White Pink pink gold Sequent,.  However, it has been shown by others that the recent web high flyers are mostly concentratedNike Womens Lunarcharge Essential Running Trainers 923620 Sneakers shoes 002,.

Some of you who follow venture returns data may be asking some questions:

  1. Nike Legend React AA1626-004 Black Atmosphere Grey Womens Running shoes, NIKE Womens Nike Free Rn 2018 Sun AH5208-001 VAST GREY SUMMIT WHITE Size 8.5,  
  2. W NIKE AIR MORE MONEY LX -NO BOX LID- SZ WMNS 6 (AJ1312 002) RETAIL 160.00,NIKE WOMENS AIR HUARACHE RUN PREMIUM METALLIC MAHOGANY WHITE AA0523 202 SZ 7,Nike Women's Free 5.0 TR Print 5 Running shoes,
  3. Women's Nike AF1 Sage Low - CHOOSE SIZE - AR5339-002 Wedge White XX Air Force 1,

Item specifics

Condition:
New with box: A brand-new, unused, and unworn item (including handmade items) in the original packaging (such as ... Read moreabout the condition
Brand:

Nike

Heel Height: Flat (0 to 1/2 in.) Style: Running, Cross Training
Color:

White/Black/Pink Pow

Width: Medium (B, M)
Country/Region of Manufacture: Vietnam Material: Multi (See Description)
Gender: Women's

NIKE W Nike Ashin Modern AJ8799-101 SUMMIT WHITE Size 6, We think that there are a few reasons:

  1. Nike Mauve Air Force 1 Sneakers With Gum Sole, – Nike womens flex 2014 RN running trainers 642767 503 sneakers shoes,
  2. NIKE WMNS AIR FORCE 1 HI HIGH PREMIUM HOT LAVA PINK SZ 7.5 [654440-800], – Nike Women Zoom Vapor Tour Tennis shoes White Silver 631475-101 s 8,Nike womens air pegasus 83 KJCRD trainers 828406 sneakers shoes,
  3. AO4550-100 Nike Air Vapormac Plus (White bluee Green Grey) Women Sneakers,–  Unlike IT where 100x returns are possible and have driven great outcomes in companies like Skype and Google, and will most likely in Zynga and Facebook, Life Sciences never will have these wild “Black Swan” outliers.. These 100x’ers are the companies that draw press attention, new talent, and more capital into the IT space.
  4. Nike Free Inneva Sail Cream Pink yeezy qs ds 598153 107 WOMEN 11, MEN 9.5, – NIKE AIR MAX PLUS LUX TN TUNED DUSTY PEACH WOMEN SIZE 8 NEW (AH6788-201),
  5. Nike Lunarsolo Light Pumice Navy-Barely Grey AA4080-016 Women's Size 10, – Nike Wmns Air Max 95 Reflect Silver White Women Running shoes Sneaker 307960-113,Nike Free Rn Flyknit 2017 Purple Women's 880844-501 Light Thistle Run OG Rare,

NIKE Womens Nike Zoom Strike AJ0188-100 WHITE WOLF GREY Womens Size 11.5,

To get all of the numbers and the full commentary, please head over to the Nature website.

For simplicity’s sake, in this post, we use the term Life Sciences to cover all of Healthcare venture capital investing and the term IT/Tech to cover all Information technology, Internet/Software, and Hardware related categories.

Nike Free 5.0 TR FIT 5 704674-100 White Metallic Silver Women's Running Sneakers,

This entry was posted in Exits IPOs M&As, VC-backed Biotech Returns. Bookmark the permalink.